Stella Han, PharmD, has joined Madrigal Pharmaceuticals as Director, R&D Scientific Engagement Strategy & Operations, bringing nearly two decades ...
SK pharmteco announced on September 22, 2026 an expanded manufacturing collaboration with Philadelphia-based Gemma Biotherapeutics ...
Michael Utz has joined Madrigal Pharmaceuticals as Senior Director, Commercial Development – Marketing, bringing 30 years of pharmaceutical ...
Neuro-Innovators has appointed Ray Jordan as lead preferred shareholder director on its Board of Directors. “Ray is a seasoned investor who brings ...
Annovis Bio, Inc., a Malvern, Pennsylvania-based Phase 3 clinical-stage biotech, announced on September 23, 2026 a collaboration with Weave Bio, an ...
Noah Kortz has joined GSK as Portfolio & Program Manager, bringing engineering, facilities, and program leadership experience across ...
Made Scientific Acquires 85,000 Sq. Ft. Pennsylvania Cell Therapy Facility, Operational From Day One
Made Scientific, Inc., a Princeton, N.J.-based clinical- and commercial-stage cell therapy CDMO, announced on September 21, 2026 that it has acquired ...
The Truman Lab at UNC Charlotte has secured a new $2.1 million, five-year grant from the National Institutes of Health, ...
Novo Nordisk and Anthropic announced a collaboration on September 16, 2026 aimed at helping Novo accelerate the development ...
Merck, known as MSD outside the U.S. and Canada, launched Your Hive of Whole Health on September 18, 2026 — a multi-year ...
The U.S. Food and Drug Administration issued a direct final rule on September 21, 2026 that updates its regulations to ...
OS Therapies Aligns With FDA on Phase 3 Design, Accepts MHRA’s Project Orbis Invitation for OST-HER2
OS Therapies, Inc., a Rockville, Maryland- and New York-based clinical-stage oncology company, announced on September 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results